BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Drug Development and Industrial Pharmacy 2017;43:283-92. [DOI: 10.1080/03639045.2016.1239627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Van Ngo H, Park C, Tran TTD, Nguyen VH, Lee BJ. Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs. Eur J Pharm Biopharm 2020;154:8-17. [PMID: 32634569 DOI: 10.1016/j.ejpb.2020.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ko DW, Cho JH, Choi HG. Development of rebamipide-loaded spray-dried microsphere using distilled water and meglumine: physicochemical characterization and pharmacokinetics in rats. Pharm Dev Technol 2021;26:701-8. [PMID: 33938359 DOI: 10.1080/10837450.2021.1924781] [Reference Citation Analysis]
3 Jindal A, Singh R, Tomar S, Dureja J, Karan M, Chadha R. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies. Pharm Res 2021. [PMID: 34904202 DOI: 10.1007/s11095-021-03132-7] [Reference Citation Analysis]
4 Xiong X, Du Q, Zeng X, He J, Yang H, Li H. Solvates and polymorphs of rebamipide: preparation, characterization, and physicochemical analysis. RSC Adv 2017;7:23279-86. [DOI: 10.1039/c7ra02895d] [Cited by in Crossref: 13] [Article Influence: 2.6] [Reference Citation Analysis]